Thrivent Financial for Lutherans raised its stake in shares of Encompass Health Corporation (NYSE:EHC – Free Report) by 57.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,194,859 shares of the company’s stock after buying an additional 437,464 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Encompass Health were worth $151,544,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Citizens National Bank Trust Department bought a new stake in Encompass Health in the 3rd quarter valued at $26,000. First Horizon Corp purchased a new position in shares of Encompass Health during the third quarter valued at about $34,000. Root Financial Partners LLC bought a new stake in shares of Encompass Health in the third quarter worth about $39,000. Newbridge Financial Services Group Inc. boosted its stake in Encompass Health by 112.5% during the second quarter. Newbridge Financial Services Group Inc. now owns 425 shares of the company’s stock valued at $52,000 after buying an additional 225 shares during the last quarter. Finally, Employees Retirement System of Texas purchased a new position in Encompass Health during the 2nd quarter valued at approximately $57,000. Institutional investors own 97.25% of the company’s stock.
Encompass Health Trading Down 0.1%
Shares of EHC opened at $94.48 on Friday. The company’s fifty day simple moving average is $106.05 and its 200-day simple moving average is $114.87. The company has a market cap of $9.51 billion, a P/E ratio of 17.86, a P/E/G ratio of 1.52 and a beta of 0.74. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a twelve month low of $92.53 and a twelve month high of $127.99.
Wall Street Analysts Forecast Growth
Several analysts have recently issued reports on EHC shares. Raymond James Financial raised Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Zacks Research downgraded shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Finally, Barclays upped their target price on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research report on Thursday, October 30th. Two investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $142.86.
View Our Latest Research Report on EHC
Encompass Health Profile
Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.
Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.
Read More
- Five stocks we like better than Encompass Health
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Deutsche Bank Just Raised Their Gold Target to $6,000
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
